SEC Form D · filed September 22, 2025
Claris Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Reza C. Dana · Jersey City, NJDirectorKenneth C. Harrison · Jersey City, NJDirectorHenry Rath · Jersey City, NJExecMarc C. De Garidel · Jersey City, NJDirectorClarke Atwell · Jersey City, NJExec · DirectorSusan Orr · Jersey City, NJExecMeredith C. Fisher · Jersey City, NJDirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorHenry Rath · Jersey City, NJExecTerese Gieselman · Vancouver, British Columbia, CanadaDirectorSusan Orr · Jersey City, NJExecShehzad Khan · NEW YORK, NYDirectorClarke Atwell · Jersey City, NJExec · DirectorLewis Teal · Vancouver, British Columbia, CanadaDirectorMark Floyd · Plano, TXDirectorAndrew T. Basham · Richmond, VADirectorS. T. Williams · Richmond, VADirectorSunriver Management LLC · Greenwich, CTDirectorLeslie G. Cohen · Boston, MAExec · DirectorAnthony Snow · Boca Raton, FLExecAgTech Fund IV GP, LLC · Saint Louis, MOExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗